This annual report documents trends in immunisation coverage in NSW for children, adolescents and the elderly, up to and including data for 2016. Methods: Data from the Australian Immunisation Register (previously known as the Australian Childhood Immunisation Register), the NSW School Vaccination Program and the NSW Population Health Survey were used to calculate various measures of population coverage, and vaccination timeliness for Aboriginal and non-Aboriginal children. Results: Greater than 93% coverage has been reached for children in NSW at 12 and 60 months of age. Coverage for individual vaccines due at these milestones was greater than 93%, except for the second dose of rotavirus vaccine at 12 months of age that was just under 90%. 'Fully immunised' coverage at 24 months of age increased to greater than 90%. Coverage for individual vaccines due at this age was greater than 94%, except for the second dose of the measles, mumps and rubella vaccine (92.7%) and the varicella vaccine (92.4%). Delayed receipt of the third dose of diphtheria, tetanus, and acellular pertussis-containing vaccine and the second dose of the measles, mumps and rubella vaccine was still an issue for Aboriginal children. Adolescent human papillomavirus vaccine coverage in 2016 for females and males was higher for the first dose (86% and 83%, respectively) and second dose (84% and 82%, respectively) compared with the third dose (80% and 78%, respectively).
Introduction

This series of New South Wales (NSW) Annual Immunisation Coverage Reports provides important information on trends and issues in vaccination coverage to facilitate the monitoring of NSW vaccination programs.
This report uses the longstanding international practice of reporting coverage at key milestone ages to measure coverage against national benchmarks and to track trends over time. It is adapted from annual national immunisation reports published since 2009. 1 High levels of reporting to the Australian Immunisation Register (AIR), previously known as the Australian Childhood Immunisation Registration (ACIR), are maintained by a system of incentive payments for immunisation providers and parents/guardians. 2 Reported vaccination coverage may be impacted by changes to immunisation policy, the incentive payment system and changes to the 'fully immunised' coverage algorithms. Some of these changes are highlighted in Box 1 and are also referred to in this report.
The ACIR was established on 1 January 1996 by incorporating demographic data from Medicare on all enrolled children aged less than 7 years. 6 Up until 31 December 2015 all vaccination records for a child remained on the register indefinitely, but no new vaccination encounter records were added after the 7th birthday.
2 From 1 January 2016 the register was changed to include records of vaccinations given up to less than 20 years of age and was further expanded from 30 September 2016 to become the AIR, which captures records of vaccinations given to eligible individuals in Australia throughout their life. 7 Participation in the AIR is opt-out so it constitutes a nearly complete population register. Persons not enrolled in Medicare can be added to the AIR via a supplementary number. Since 2001, vaccinations given overseas may be recorded if a provider endorses their validity. Data are transferred to the AIR when a recognised immunisation provider supplies details of an eligible vaccination either via medical practice software or through the internet using the Medicare Australia website or by submitting paper encounter forms. The existence of medical contraindications and conscientious objection to vaccination was previously recorded on the register, but as of 1 January 2016 conscientious objection is no longer a valid reason for vaccination exemption and so data are no longer available. April 2015: New immunisation requirements for federal government family assistance payments (the 'No Jab, No Pay' policy4) came into effect. Only parents of children (aged less than 20 years) who are 'fully immunised' or on a recognised catch-up schedule continue to receive the Child Care Benefit, Child Care Rebate, and/or the Family Tax Benefit Part A end-of-year supplement. Children with medical contraindications or natural immunity for certain diseases continue to be exempt from the requirements; however, conscientious objection is no longer a valid exemption from immunisation requirements.
March 2015:
Booster dose of DTPa recommended at 18 months of age in NSW.
The dTpa vaccine was funded by NSW for women during the third trimester of pregnancy and for new mothers in maternity units of public hospitals (if not vaccinated in the third trimester) under the cocoon strategy.
Seasonal influenza vaccine added to the NIP schedule for Aboriginal and Torres Strait Islander children aged 6 months to less than 5 years. List of population groups for which seasonal influenza vaccination is recommended further expanded to include Aboriginal and Torres Strait Islander children aged 5 to less than 15 years. The recommended upper age for children requiring two doses in the first year they receive influenza vaccine changed from less than 10 years to less than 9 years.
December 2014: Secondary school HPV vaccine catch-up program for Year 9 male students ceased.
Immunisation coverage assessment algorithm for 'fully immunised' at the 24-month milestone amended to require a dose of meningococcal C vaccine, a dose of varicella vaccine and a second dose of a measles-mumps-rubella (MMR) vaccine. The expansion of the definition of 'fully immunised' reinforces the importance of these vaccines by linking them to payments to families and immunisation providers.
change to the childhood schedule in 2016 was in April, with the addition of a booster dose of the diphtheria, tetanus, and acellular pertussis-containing vaccine (DTPa) at 18 months of age.
Methods
Measuring vaccination coverage using the Australian Immunisation Register
This report details vaccination coverage for 2016 using AIR data up to 31 March 2017. The cohort method has been used for calculating coverage at the population level (national and state/territory) 8 since the inception of the immunisation register. Cohort vaccination status is assessed at 12 months of age (for vaccines due at 6 months), 24 months of age (for vaccines due at 12 and 18 months), and 5 years of age (for vaccines due at 4 years). A 3-month lag period is allowed for the late notification of vaccinations to the AIR. 8 If a child's record indicates receipt of the last dose of a vaccine that requires more than one dose to complete the series, it is assumed that earlier vaccinations in the sequence have been given. This assumption has been shown to be valid. 9, 10 The proportion of children designated as 'fully immunised' is calculated using 12-month-wide cohorts with the number of children completely vaccinated with the vaccines of interest by the designated age as the numerator, and the total number of Medicare-registered children in the age cohort as the denominator. The 12-month wide cohorts used are children born between 1 January 2015 and 31 December 2015 for the 12-month milestone, between 1 January 2014 and 31 December 2014 for the 24-month milestone, and between 1 January 2011 and 31 December 2011 for the 5-year (60-month) milestone. 'Fully immunised' at 12 months of age is defined as a child having a record on the AIR of a third dose of the SA3s were chosen as areas to be mapped because they provide more detail than LHDs but are not too small to render maps unreadable (population sizes for a year-wide birth cohort of children for SA3s in NSW range from 110 to 2799 children). SA3s with a population size for a year-wide birth cohort of children less than 26 were excluded from any mapping due to the imprecision of any coverage estimates calculated for these areas. Maps were created using MapInfo mapping software 12 and the ABS Census Boundary Information. As postcode is the only geographical indicator on the AIR, the ABS Postal Area to SA3 Concordance 2011 was used to match AIR residential postcodes of the children to SA3s. Elderly people Influenza and pneumococcal vaccination coverage estimates in the elderly were from the NSW Population Health Survey. This is a rolling telephone survey utilising random digit dialling, with vaccination status determined from patient recall to interview questions asking 'Were you vaccinated or immunised against flu in the last 12 months?' and 'When were you last vaccinated or immunised against pneumonia?'
Summary of results
Coverage (all children)
• Overall in NSW 'fully immunised' coverage measured at the 12-month milestone increased from 92.8% in 2015 to 93.5% in 2016 ( Figure 1 , Table 2 ).
• 'Fully immunised' coverage in NSW measured at the 24-month milestone increased from 89.6% in 2015 to 90.5% in 2016 ( Figure 1 , Table 3 ).
• NSW coverage measured at the 5-year milestone remained relatively stable between 2015 (93.1%) and 2016 (93.2%) ( Figure 1 , Table 4 ).
• 'Fully immunised' coverage at 12 months of age increased in 2016 in all LHDs in NSW except for Far West, Network with Victoria and Northern NSW, where marginal decreases were seen (Table 2 ).
• Coverage at 12 months of age for all individual vaccines (except rotavirus) in 2016 increased to greater than or equal to 94% in NSW overall ( Figure 2 ) and greater than 93% for all LHDs except Mid North Coast and Northern NSW ( Table 2 ).
• Coverage for rotavirus in NSW increased by more than 2 percentage points in 2016 to 89.9% (Table 2 ). In the last quarter of 2016, coverage for rotavirus in NSW reached 90.5% ( Figure 2 ). Coverage for rotavirus remains lower than other vaccines as catch-up cannot be given once infants turn 15 weeks (dose 1) and 25 weeks (dose 2) of age.
• For all LHDs, except Sydney, 'fully immunised' coverage at 24 months of age increased in 2016. At this milestone, 'fully immunised' coverage remained below 90% for Mid North Coast, Northern NSW, Northern Sydney, South Eastern Sydney, South Western Sydney, Sydney and Western Sydney, but was above 92% in all other LHDs in NSW (Table 3 ).
• Coverage in NSW for all individual vaccines (except the second dose of MMR and varicella) at the 24-month milestone remained greater than 94% in 2016 (Table 3 , Figure 3 ) and increased to greater than 93% for all LHDs except for Northern NSW (Table 3 ).
• In NSW during 2016, the fourth dose of Haemophilus influenzae type b vaccine and the dose of meningococcal C vaccine were mostly given as the combined vaccine MenitorixÒ at 12 months of age (98.1%).
• In 2016, coverage at 24 months of age for the first dose of MMR was 94.9% ( (Table 3) . Coverage of the second dose of MMR at 5 years of age was higher at 94.1% ( • 'Fully immunised' coverage and coverage for all individual vaccines for the 5-year milestone in NSW remained greater than 93% in 2016 (Table 4 , Figure 4 ) and greater than 90% in all LHDs except Northern NSW (Table 4) .
Indigenous coverage
• In 2016, 'fully immunised' coverage for NSW Aboriginal children at the 12-month milestone increased by 1.8 percentage points to 93.8% ( (Table 5 ).
• 'Fully immunised' coverage for NSW Aboriginal children at the 60-month milestone increased by 1 percentage point to 96.6% in 2016 (Table 5 ), higher than for non-Aboriginal children at the same age (93.0%).
• At the 60-month milestone, 'fully immunised' coverage was higher in 2016 for Aboriginal compared with nonAboriginal children in all LHDs (Table 5 ).
• Coverage estimates for all individual vaccines in 2016
were similar or marginally lower in Aboriginal children at 12 months of age compared with non-Aboriginal children (Table 6 ). However, coverage for rotavirus vaccine was 2 percentage points lower in Aboriginal children.
• Coverage estimates for all individual vaccines in 2016 were higher in Aboriginal children at 24 months of age compared with non-Aboriginal children, including the second dose of MMR and the varicella vaccine, which both increased by more than 2 percentage points (Table 6 ). • Coverage estimates for all individual vaccines in 2016 remained higher in Aboriginal children at 60 months of age compared with non-Aboriginal children (Table 6) . vaccine between 6 and less than 8 weeks increased to 84% (Figure 7 ). This percentage has been increasing since 2009 when vaccination at 6 weeks was encouraged to provide early protection against pertussis.
Small area coverage
• Coverage by small area (SA3) varied across the state for rotavirus (77.6-95.5%) and pneumococcal conjugate vaccines (81.8-97.5%) measured at the 12-month milestone, and the second dose of MMR (82.4-97.1%) measured at the 24-month milestone (Figures 8-10 ).
Adolescent coverage
• Coverage in adolescents varied by vaccine and dose with coverage for varicella vaccine substantially lower in 2016 than the coverage estimates for the first two doses of HPV vaccine (both females and males) and the dTpa vaccine (Table 9 ).
• Varicella vaccine is recommended in the school program for children not previously vaccinated or who have not had the disease. Coverage for this vaccine increased by 4 percentage points to 70% in 2016 (Table 9 ).
• Coverage of each dose of HPV was higher in female Year 7 students than their male counterparts. Coverage of the third dose was lower, compared with the first and second doses, in both females and males (Table 9 , Figure 11 ). Figure 12 ). In 2016, 71.6% of surveyed adults reported they had received influenza vaccine in the previous 12 months. Coverage varied from 65.7% in the Northern Sydney LHD to 75.9% in the Far West (Table 10 ).
• The percentage of people aged 65 years and over reporting ever having received pneumococcal vaccination (23-valent pneumococcal polysaccharide vaccine) in 2016 was 47.0%, considerably lower than influenza vaccine coverage. There was variation in reported vaccination between LHDs, ranging from 37.0% in Sydney to 53.2% in the Far West (Table 10) . • The percentage of people reporting pneumococcal vaccination has been decreasing since 2011 ( Figure 12 ) when it was recommended that non-Indigenous adults aged 65 years and over who do not have any condition predisposing them to an increased risk of invasive pneumococcal disease no longer required a repeat dose. It is possible that difficulty in recall may result in underestimation of pneumococcal vaccine uptake. Self-reported vaccination coverage in the elderly suggests that almost three-quarters of adults aged 65 years and over receive an annual influenza vaccine; however, less than half report ever receiving the pneumococcal vaccine.
The AIR, the NSW Population Health Survey and monitoring through the NSW School Vaccination Program continue to be very useful tools for administering the National Immunisation Program and monitoring its implementation in NSW. 
